Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Aarti Pharmalabs Ltd

AARTIPHARM.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Small Cap Analyst: HOLD

Last Close

$8.92

▼ -2.57%

Market Cap $808.75M · Vol 395.28K

Key Metrics

P/E Ratio

36.22

FWD: 43.82

Market Cap

$808.75M

Small Cap

Div Yield

0.47%

Semi-annual dividend

EPS Growth

-8.77%

YoY

RSI (14)

76.26

Momentum

Beta

1.03

vs Market

52W High

$9.91

17.18% below

52W Low

$6.13

43.85% above

Volume

395.28K

Avg 867.86K

P/B

2.53

Price-to-book

ROE

8.90%

Return on equity

Free Float

55.78%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Aarti Pharmalabs Ltd (AARTIPHARM.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does AARTIPHARM.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+24.11%

+19.93%

+18.35%

+20.02%

YTD

+13.13%

+12.36%

+115.13%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$194.68M
Net Income	$18.69M
Revenue Growth (YoY)	+38.74%
Gross Margin	48.38%
Operating Margin	16.38%
Net Profit Margin	9.60%
ROE	8.90%
ROA · ROIC	7.30% · 7.88%

P/E Ratio	36.22
Forward P/E (FY1)	43.82
PEG Ratio	-0.86
P/S	2.95
P/B	2.53
P/FCF	N/A
EPS Growth	-8.77%
Outstanding Shares	90.68M

Technical Indicators

50-Day SMA	$7.31
200-Day SMA	$7.52
RSI (14)	76.26
Beta	1.03
52-Week High	$9.91
52-Week Low	$6.13

Volume Today	395.28K
Avg Daily Volume (30D)	867.86K
Relative Volume	0.46x
Volatility (10D)	92.64
Volatility (30D)	60.90
Free Float	55.78%

Analyst Consensus

HOLD

Current Price $8.92

Mean Target $7.79

52W Low$6.13 52W High$9.91

Current

Target

$6.13 $9.91

Current Analyst target

-12.65% downside risk · 1 analysts

Identifiers

ExchangeNSE India

FIGIBBG0127VFCQ7

ISININE0LRU01027

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateNov 7, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Aarti Pharmalabs Limited is engaged in the manufacturing of active pharmaceutical ingredients (APIs), advanced intermediates, and xanthine derivatives, based in India. The Company also offers comprehensive contract development and manufacturing organization (CDMO) and CMO services for drug substances and new chemical entities (NCE), including their key starting materials (KSM) and regulatory starting materials (RSM), serving various pharmaceutical companies worldwide with a focus on the Ph-I/II/III, launch, and commercial phases. It has dedicated facilities for the production of HPAPIs, corticosteroids, cytotoxic medicines, and oncology products. Its caffeine products include caffeine anhydrous, and caffeine anhydrous (granules). Its range of API products include Ramipril, Quinapril HCL, Budesonide, Bambuterol HCL, Apixaban, Rivaroxaban, Cinacalcet and others. Its products are exported to key regulated markets such as the United States (US), the European Union, and Japan.